Indefinite Delivery Contract SPE2DX15D3516

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract encompasses a broad spectrum of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items across multiple therapeutic areas. The agency has issued numerous Delivery Orders against the IDC for specific pharmaceutical and medical products, all without any set-aside requirements, reflecting Amerisourcebergen's strong position in the federal healthcare supply market. In addition to the DLA contract, Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.

The purpose of this IDC is to provide the DLA and other federal agencies efficient access to a comprehensive portfolio of pharmaceutical and medical supplies necessary to support military treatment facilities, veterans' healthcare programs, and other government medical institutions. The contract's broad scope and substantial ceiling value demonstrate Amerisourcebergen's ability to meet the diverse and critical pharmaceutical needs of the DoD and other federal customers on a large scale, leveraging its extensive supply chain and distribution expertise in the healthcare sector.